null

 

Exhibit 23.1

 


 

  Fahn Kanne & Co.
  Head Office
  32 Hamasger Street
  Tel-Aviv 6721118, ISRAEL
  PO Box 36172, 6136101
   
  T +972 3 7106666
  F +972 3 7106660
  www.gtfk.co.il

 

CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our report dated March 28, 2024, with respect to the consolidated financial statements of Glucotrack, Inc., included in the Annual Report on Form 10-K for the year ended December 31, 2023, which is incorporated by reference in this Registration Statement on Form S-1. We consent to the incorporation by reference of the aforementioned report in the Registration Statement, and to the use of our name as it appears under the caption “Experts”.

 

FAHN KANNE & CO. GRANT THORNTON ISRAEL

 

Tel-Aviv, Israel

 

September 16, 2024

 

Certified Public Accountants

Fahn Kanne & Co. is the Israeli member firm of Grant Thornton International Ltd.

 

 

 

S-1 EX-FILING FEES 0001506983 0001506983 1 2024-09-16 2024-09-16 0001506983 2024-09-16 2024-09-16 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-1

Glucotrack, Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common Stock, par value $0.001 per share   (1)   457(o)       $     $ 1,000,000.00   0.00014760   $ 147.60
                                           
Total Offering Amounts:   $ 1,000,000.00         147.60
Total Fees Previously Paid:                
Total Fee Offsets:                
Net Fee Due:             $ 147.60

 

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416(a) promulgated under the U.S. Securities Act of 1933, as amended (the “Securities Act”), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions.
v3.24.3
Submission
Sep. 16, 2024
Submission [Line Items]  
Central Index Key 0001506983
Registrant Name Glucotrack, Inc.
Form Type S-1
Submission Type S-1
Fee Exhibit Type EX-FILING FEES
v3.24.3
Offerings - Offering: 1
Sep. 16, 2024
USD ($)
Offering:  
Fee Previously Paid false
Rule 457(o) true
Security Type Equity
Security Class Title Common Stock, par value $0.001 per share
Maximum Aggregate Offering Price $ 1,000,000.00
Fee Rate 0.01476%
Amount of Registration Fee $ 147.60
Offering Note Pursuant to Rule 416(a) promulgated under the U.S. Securities Act of 1933, as amended (the “Securities Act”), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions.
v3.24.3
Fees Summary
Sep. 16, 2024
USD ($)
Fees Summary [Line Items]  
Total Offering $ 1,000,000.00
Total Fee Amount 147.60
Net Fee $ 147.60

GlucoTrack (NASDAQ:GCTK)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos GlucoTrack.
GlucoTrack (NASDAQ:GCTK)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos GlucoTrack.